OKYO · OKYO Pharma Ltd
$1.55
+0.00 (+0.00%)
At close · Aug 27
Market Cap
$80.29M
Shares
52.48M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.55
Open$1.55
Day$1.53–1.58
52W close$1.37–3.11
Avg vol 30d97K
Short int83K · 0.2% float · 1.2d
Short vol14%
DataMay 2022–Aug 2026
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Very Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.64
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−13%
below
Price vs 50-day avg
−0%
below
RSI (14)
51
neutral
MACD trend
Positive
52-week position
10%
near low
Momentum
relative strength
1-month return
−5%
trailing
6-month return
−8%
trailing
YTD return
−25%
this year
Relative strength
−21%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+58% holders QoQ · +8 funds added
Insider flow
Accumulating
Net +$136.0K over 90 days · 0% sells
Short interest
Falling
0.16% of float · ▼ -38.4% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
19 holders — near 3-yr high, broad support
Squeeze score
25
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
76%
annualized · 1-yr
Max drawdown
−56%
past year
ATR
5.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−13%
Bearish
Price vs 50-day avg
−0%
Neutral
RSI (14)
51
Neutral
MACD trend
Positive
Bullish
52-week position
10%
Bearish
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+58% holders QoQ · +8 funds added
Insider flow
Accumulating
Net +$136.0K over 90 days · 0% sells
Short interest
Falling
0.16% of float · ▼ -38.4% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
19 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1
Now $2 · 10%
Range high $3
vs 200-day avg -13%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OKYO
this stock
OKYO Pharma Ltd
|
$80.29M | -25.1% | — | — | 0.2% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.72B | +20.7% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.89B | +5.6% | +20.8% | 20.2 | 2.3% |
|
ARGX
Argenx SE
|
$65.12B | +24.5% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.92B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
19
- % held
- 12.4%
- Net QoQ
- +104.0K sh
- Top holder
- Woodline Partners LP
Held
Float
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OKYO | +2.7% | -5.5% | -8.3% | -7.7% | -25.1% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | +3.0% | -10.5% | -20.7% | -10.3% | -37.5% |